JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 21, 2003; DOI: 10.1124/jpet.103.061853


0022-3565/04/3083-896-903$20.00
JPET 308:896-903, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.061853v1
308/3/896    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. H.
Right arrow Articles by Hong, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. H.
Right arrow Articles by Hong, K. W.

NEUROPHARMACOLOGY

Cilostazol Prevents Focal Cerebral Ischemic Injury by Enhancing Casein Kinase 2 Phosphorylation and Suppression of Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation in Rats

Jeong Hyun Lee, Ki Young Kim, Yong-Kyu Lee, So Youn Park, Chi Dae Kim, Won Suk Lee, Byung Yong Rhim, and Ki Whan Hong

Department of Pharmacology (J.H.L., K.Y.K., S.Y.P., C.D.K., W.S.L., B.Y.R., K.W.H.), College of Medicine, Pusan National University, Busan, Korea; and Department of Molecular Biochemistry and Toxicology (Y.-K.L.), Dongseo University, Busan, Korea

This study shows the in vivo neuroprotective effect of cilostazol against cerebral ischemic injury evoked by subjecting rats to 2-h occlusion of middle cerebral artery (MCAO) followed by 24-h reperfusion. We observed the signaling pathway by which cilostazol suppressed MCAO-induced increased phosphorylation of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) and apoptosis via increased phosphorylation of casein kinase 2 (CK2). When rats received 30 mg/kg cilostazol orally two times at 5 min and 4 h after the completion of ischemia, the infarct area was significantly reduced in the cortex and striatum with improvement of neurological deterioration. Increased DNA fragmentation in the penumbral zone was significantly reduced by cilostazol. Cilostazol significantly elevated phosphorylation levels of CK2, Akt, and cyclic AMP response element-binding protein (CREB) in association with increased Bcl-2 in the ischemic area, whereas the elevated PTEN phosphorylation was significantly reduced, all of which were antagonized by iberiotoxin, a maxi-K channel blocker, administered intracisternally 30 min before ischemia. In conclusion, cilostazol ameliorates the neuronal damage by suppression of apoptotic cell death via the maxi-K channel opening-coupled up-regulation of CK2 phosphorylation and down-regulation of PTEN phosphorylation with resultant increase in the Akt and CREB phosphorylation and increased Bcl-2 protein.


Received for publication October 20, 2003
Accepted November 19, 2003.

Address correspondence to: Dr. Ki Whan Hong, Department of Pharmacology, College of Medicine, Pusan National University, 10 Ami-Dong, 1-Ga, Seo-Gu, Busan 602-739, Korea. E-mail: kwhong{at}pusan.ac.kr




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Nonaka, A. Koumura, K. Hyakkoku, M. Shimazawa, S. Yoshimura, T. Iwama, and H. Hara
Combination Treatment with Normobaric Hyperoxia and Cilostazol Protects Mice against Focal Cerebral Ischemia-Induced Neuronal Damage Better Than Each Treatment Alone
J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 13 - 22.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Martin, R. Brenneman, E. Golden, T. Walent, K. G. Becker, V. V. Prabhu, W. Wood III, B. Ladenheim, J.-L. Cadet, and S. Maudsley
Growth Factor Signals in Neural Cells: COHERENT PATTERNS OF INTERACTION CONTROL MULTIPLE LEVELS OF MOLECULAR AND PHENOTYPIC RESPONSES
J. Biol. Chem., January 23, 2009; 284(4): 2493 - 2511.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. Nishimura, J. Ishigooka, Y. Imamura, and S. Ihara
Cilostazol, a cAMP Phosphodiesterase 3 Inhibitor, in the Treatment of Poststroke Depression
J Neuropsychiatry Clin Neurosci, November 1, 2007; 19(4): 471 - 472.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Zhao, T. Shimohata, J. Q. Wang, G. Sun, D. W. Schaal, R. M. Sapolsky, and G. K. Steinberg
Akt Contributes to Neuroprotection by Hypothermia against Cerebral Ischemia in Rats
J. Neurosci., October 19, 2005; 25(42): 9794 - 9806.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Ning, L. Pei, M. Liao, B. Liu, Y. Zhang, W. Jiang, J. G. Mielke, L. Li, Y. Chen, Y. H. El-Hayek, et al.
Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTEN
J. Neurosci., April 21, 2004; 24(16): 4052 - 4060.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.